| 000 | 01777 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250518092147.0 | ||
| 264 | 0 | _c20201027 | |
| 008 | 202010s 0 0 eng d | ||
| 022 | _a1475-6374 | ||
| 024 | 7 |
_a10.1080/14756366.2020.1740695 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Husseiny, Walaa M | |
| 245 | 0 | 0 |
_aSynthesis, antitumor activity, and molecular docking study of 2-cyclopentyloxyanisole derivatives: mechanistic study of enzyme inhibition. _h[electronic resource] |
| 260 |
_bJournal of enzyme inhibition and medicinal chemistry _cDec 2020 |
||
| 300 |
_a744-758 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnisoles _xchemical synthesis |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCyclic Nucleotide Phosphodiesterases, Type 4 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Docking Simulation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPhosphodiesterase 4 Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 700 | 1 | _aEl-Sayed, Magda A-A | |
| 700 | 1 | _aEl-Azab, Adel S | |
| 700 | 1 | _aAlSaif, Nawaf A | |
| 700 | 1 | _aAlanazi, Mohammed M | |
| 700 | 1 | _aAbdel-Aziz, Alaa A-M | |
| 773 | 0 |
_tJournal of enzyme inhibition and medicinal chemistry _gvol. 35 _gno. 1 _gp. 744-758 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/14756366.2020.1740695 _zAvailable from publisher's website |
| 999 |
_c30752336 _d30752336 |
||